Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Tax Provisions (2017 - 2025)

Historic Tax Provisions for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to -$407000.0.

  • Organogenesis Holdings' Tax Provisions rose 9374.62% to -$407000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 14695.02%. This contributed to the annual value of $7.1 million for FY2024, which is 2944.74% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Tax Provisions stood at -$407000.0, which was up 9374.62% from -$2.4 million recorded in Q2 2025.
  • Organogenesis Holdings' Tax Provisions' 5-year high stood at $13.3 million during Q4 2024, with a 5-year trough of -$32.1 million in Q4 2021.
  • For the 5-year period, Organogenesis Holdings' Tax Provisions averaged around -$1.2 million, with its median value being $200000.0 (2021).
  • Over the last 5 years, Organogenesis Holdings' Tax Provisions had its largest YoY gain of 170370.37% in 2021, and its largest YoY loss of 820757.58% in 2021.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Tax Provisions stood at -$32.1 million in 2021, then soared by 103.95% to $1.3 million in 2022, then tumbled by 196.85% to -$1.2 million in 2023, then skyrocketed by 1182.98% to $13.3 million in 2024, then crashed by 103.06% to -$407000.0 in 2025.
  • Its Tax Provisions stands at -$407000.0 for Q3 2025, versus -$2.4 million for Q2 2025 and -$6.9 million for Q1 2025.